The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, E-Book by Ann Mullally, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Ann Mullally, MD ISBN: 9780323532365
Publisher: Elsevier Health Sciences Publication: July 14, 2017
Imprint: Elsevier Language: English
Author: Ann Mullally, MD
ISBN: 9780323532365
Publisher: Elsevier Health Sciences
Publication: July 14, 2017
Imprint: Elsevier
Language: English

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

More books from Elsevier Health Sciences

Cover of the book Trouble déficit de l'attention avec ou sans hyperactivité by Ann Mullally, MD
Cover of the book Public Health Nursing - E-Book by Ann Mullally, MD
Cover of the book Common Complications in Orthopedics, An Issue of Orthopedic Clinics, E-Book by Ann Mullally, MD
Cover of the book Depressionen by Ann Mullally, MD
Cover of the book ECGs Made Easy - E-Book by Ann Mullally, MD
Cover of the book Year Book of Surgery 2014, E-Book by Ann Mullally, MD
Cover of the book Plastic Surgery E-Book by Ann Mullally, MD
Cover of the book Mechanisms of Clinical Signs - E-Book by Ann Mullally, MD
Cover of the book Advances in Equine Imaging, An Issue of Veterinary Clinics: Equine Practice - E-Book by Ann Mullally, MD
Cover of the book Global Hematology, An Issue of Hematology/Oncology Clinics of North America, E-Book by Ann Mullally, MD
Cover of the book Verletzungen im Fußball by Ann Mullally, MD
Cover of the book Navigating Problem Based Learning by Ann Mullally, MD
Cover of the book Saunders Comprehensive Review for the NCLEX-RN® Examination by Ann Mullally, MD
Cover of the book Crash Course Haematology and Immunology E-Book by Ann Mullally, MD
Cover of the book Shiatsu in der Praxis by Ann Mullally, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy